about
Symptomatic treatment of the cough in whooping coughStimuli-Responsive Polymeric Systems for Controlled Protein and Peptide Delivery: Future Implications for Ocular DeliveryBypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia TherapyA review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injuryA Review of Injectable Polymeric Hydrogel Systems for Application in Bone Tissue Engineering"On-The-Spot" Arresting of Chondroitin Sulphate Proteoglycans: Implications for Ovarian Adenocarcinoma Recognition and InterventionA review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infectionsIntegration of biosensors and drug delivery technologies for early detection and chronic management of illnessEvaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method.Box-Behnken experimental design in the development of a nasal drug delivery system of model drug hydroxyurea: characterization of viscosity, in vitro drug release, droplet size, and dynamic surface tensionEx Vivo and In Vivo Characterization of Interpolymeric Blend/Nanoenabled Gastroretentive Levodopa Delivery Systems.Unconventional dissolution methodologies.The response effect of pheochromocytoma (PC12) cell lines to oxidized multi-walled carbon nanotubes (o-MWCMTs)In silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy.Investigation of the physicochemical and physicomechanical properties of a novel intravaginal bioadhesive polymeric device in the pig model.An epichlorohydrin-crosslinked semi-interpenetrating GG-PEO network as a xerogel matrix for sustained release of sulpirideSynthesis of a semi-interpenetrating polymer network as a bioactive curcumin filmA review on composite liposomal technologies for specialized drug delivery.A composite polyelectrolytic matrix for controlled oral drug delivery.Tuberculosis chemotherapy: current drug delivery approaches.In vivo evaluation of a mucoadhesive polymeric caplet for intravaginal anti-HIV-1 delivery and development of a molecular mechanistic model for thermochemical characterization.In silico affinity profiling of neuroactive polyphenols for post-traumatic calpain inactivation: a molecular docking and atomistic simulation sensitivity analysis.A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix.A Co-blended Locust Bean Gum and Polymethacrylate-NaCMC Matrix to Achieve Zero-Order Release via Hydro-Erosive ModulationNovel high-viscosity polyacrylamidated chitosan for neural tissue engineering: fabrication of anisotropic neurodurable scaffold via molecular disposition of persulfate-mediated polymer slicing and complexation.In vivo evaluation of a conjugated poly(lactide-ethylene glycol) nanoparticle depot formulation for prolonged insulin delivery in the diabetic rabbit modelAdvances in the treatment of Parkinson's disease.Physicomechanical characterization and optimization of EDTA-mPEG and Avicel®-EDTA-mPEG in situ melt dispersion mini-pelletsTrends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disordersEvaluation of the impacts of formulation variables and excipients on the drug release dynamics of a polyamide 6,10-based monolithic matrix using mathematical tools.Patenting of nanopharmaceuticals in drug delivery: no small issue.Stimuli-responsive polymers and their applications in drug delivery.Experimental design for the formulation and optimization of novel cross-linked oilispheres developed for in vitro site-specific release of Mentha piperita oil.Nanotechnological applications for the treatment of neurodegenerative disorders.Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors.Gastroretentive drug delivery systems: current developments in novel system design and evaluation.Rapidly disintegrating oramucosal drug delivery technologies.Drug delivery technologies for chronotherapeutic applications.A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS.
P50
Q24247786-9ADAAEF1-C806-486D-AAA8-160F4EDA1F87Q26740005-10B01F4F-231D-4680-8A30-52C239865517Q26780502-D4DC7E49-F879-47F1-AE62-7C966C2FEC8FQ27027789-C1317ACC-54C1-48CA-9A68-7EADDE2B7087Q28077493-73DC28CD-F332-4EA3-BEE0-3F389710FEBBQ28828562-7479A25F-6627-46DC-9207-DDD7B9925D00Q30369008-46EDBAD6-6E41-48AD-B819-C24E73CDC2B2Q30451853-62D97981-274C-418F-B3D4-62F98343095AQ31987737-51234198-E6E9-4743-A948-0195CC463F81Q33231485-4C469AD0-BCFA-4905-9CC4-E90FA4F78175Q33654487-ADB0EBD0-8D1D-4E2F-B978-C4F3C0E01628Q33729735-5D6129A2-8F24-48A4-B345-11C6768F1639Q33751600-1AA1ED94-CCCC-4E38-8D0E-112EACE83557Q33826249-920215AE-07F9-4EE2-86BD-A9282D403353Q33986007-D18D873E-7177-4DAB-AD27-1A34A912E012Q34265163-B3088A44-4B91-4DAC-BDD1-0B6E91FBA98FQ34577416-A132B06E-67E9-4446-AFE4-9CF68E3767D6Q34730109-1DF67D58-C687-4608-B3F6-7E7A555564C5Q34733839-4C3A0FB1-F9C9-4928-B6E7-68A54214F505Q35069271-BB1CB645-73EA-4F8B-86D9-F1C331696B00Q35222477-119E4AA9-8D30-4E61-925B-C078FB6D0337Q35535250-006A6EC7-DA1D-4540-B240-C8CD88DFF184Q35868332-5727D45B-A54C-4C65-85BD-87E6078FE529Q36337349-AB00AA6A-03A6-4C6A-BD62-02B9B4E6F912Q36432409-3064EB89-AD0F-4672-8BED-17714FD8D260Q36617821-E9076ABD-1F0C-4724-A4FC-FB4456EC495BQ36720216-AF74C991-CAF1-4CEE-BFC7-DBA9B7E3C4E5Q37126411-408A622E-F74F-405F-924C-0B257AFD09FCQ37249765-E2325401-4F60-4CEE-B2D3-34E7027815A3Q37343505-F38E563E-DC51-42C0-880C-99C694472930Q37347776-837AD472-C74E-4A86-BF24-F7B72AD3E79DQ37406643-76FC3FD1-F6F6-4DB1-9BC3-DFD3DA858EBEQ37444882-96E46752-CC40-4472-BD1F-41C7690A62CCQ37504055-D23DD2E7-5157-4C82-9CE6-6CCFEFD8CE0DQ37525035-579534B6-7F9B-4563-8931-32E464F24686Q37596475-D8C8AAD0-BE23-4DB3-92A4-4E36F42B8FF9Q37626036-AD2F79A3-114A-4D9C-9B6A-0A918EEAF525Q37626038-FC1223CA-115B-40FB-98DF-6E3820E143F8Q37628600-0E970152-F61B-4233-B5F9-93040A54BF36Q37634681-859F6F1D-0AD0-4F0E-9D84-040FBDE5CC51
P50
description
hulumtues
@sq
onderzoeker uit Zuid-Afrika
@nl
researcher
@en
südafrikanischer Forscher
@de
հետազոտող
@hy
name
Viness Pillay
@ast
Viness Pillay
@de
Viness Pillay
@en
Viness Pillay
@es
Viness Pillay
@nl
Viness Pillay
@sl
type
label
Viness Pillay
@ast
Viness Pillay
@de
Viness Pillay
@en
Viness Pillay
@es
Viness Pillay
@nl
Viness Pillay
@sl
altLabel
Pillay V
@en
Pillay V.
@en
Pillay
@en
V Pillay
@en
V. Pillay
@en
prefLabel
Viness Pillay
@ast
Viness Pillay
@de
Viness Pillay
@en
Viness Pillay
@es
Viness Pillay
@nl
Viness Pillay
@sl
P166
P106
P166
P1960
RSfUGncAAAAJ
P21
P31
P496
0000-0002-8119-3347